"It's a 'no code' style approach for biologists and we also release an [open source] SDK - software development kit - allowing bioinformaticians to build real applications," CEO Stan Poslavsky tells TechCrunch.
"During my and our founders' scientific career, we saw a huge inefficiency . . . in how modern therapies, how modern drugs, are developed," he explains.
"There's also a need for biologists to aggregate and integrate results from multiple analyses, he says. 'In a unified picture, allowing you to understand what's going on.'"
Collection
[
|
...
]